TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
253,301
|
242,244
|
166,530 |
Financial expenses |
796
|
7
|
1 |
Earnings before taxes |
84,179
|
123,871
|
46,104 |
EBITDA |
81,243
|
122,476
|
46,825 |
Total assets |
184,924
|
178,869
|
147,319 |
Current assets |
174,763
|
170,927
|
139,348 |
Current liabilities |
81,269
|
53,683
|
21,553 |
Equity capital |
96,884
|
120,733
|
122,033 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
17
|
11
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.4%
|
67.5%
|
82.8% |
Turnover per employee |
14,900
|
22,022
|
27,755 |
Profit as a percentage of turnover |
33.2%
|
51.1%
|
27.7% |
Return on assets (ROA) |
46.0%
|
69.3%
|
31.3% |
Current ratio |
215.0%
|
318.4%
|
646.5% |
Return on equity (ROE) |
86.9%
|
102.6%
|
37.8% |
Change turnover |
11,057
|
75,714
|
166,530 |
Change turnover % |
5%
|
45% | |
Chg. No. of employees |
6
|
5
|
4 |
Chg. No. of employees % |
55%
|
83%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.